• Спецпроекты
  • Weather forecast
    • Exchange Rates
    • 427.02
    • 518
    • 5.92
  • SEND YOUR NEWS TO US WhatsApp +7 (777) 001 44 99

site.news_by_theme pharmaceutics

Biotech stocks fall as Clinton slams high drug prices
Biotech stocks fall as Clinton slams high drug prices

Biotech stocks took a hit after Democratic presidential frontrunner Hillary Clinton pledged to take action against runaway price increases on specialty drugs.

Biotech stocks fall as Clinton slams high drug prices
Photo courtesy of puretraining.se
French drugmaker delivers first semi-synthetic malaria drugs

French pharmaceutical giant Sanofi announced the delivery of the first anti-malaria drugs to millions of patients in Africa.

French drugmaker delivers first semi-synthetic malaria drugs
©Reuters/Tami Chappelll
FedEx indicted for shipping illegal online pharmacy meds

The US Justice Department announced that package-delivery giant FedEx has been indicted for allegedly facilitating the distribution of controlled substances and prescription drugs sold by illegal online pharmacies.

FedEx indicted for shipping illegal online pharmacy meds
©Reuters/Danish Siddiqui
Japan prosecutors arrest ex-Novartis employee over data

Prosecutors on Wednesday arrested a former employee of the Japanese unit of Swiss pharmaceutical giant Novartis for allegedly manipulating research data to exaggerate the benefits of a popular blood-pressure drug.

Japan prosecutors arrest ex-Novartis employee over data
©Reuters/Ina Fassbender
Germany's Bayer says new products drive Q1 growth

German chemicals and pharmaceuticals giant Bayer, maker of Aspirin, said on Monday it turned in a better first quarter performance than expected thanks to healthy growth driven by new products.

Germany's Bayer says new products drive Q1 growth
GSK, Novartis unveil major healthcare revamp
GSK, Novartis unveil major healthcare revamp

British pharmaceutical giant GlaxoSmithKline and Swiss peer Novartis announced a major shake-up of their healthcare divisions on Tuesday in deals worth billions of dollars.

GSK, Novartis unveil major healthcare revamp
Photo courtesy of genericpharmafinance.com
Indian drug maker Sun to buy troubled peer Ranbaxy for $4.0 bln

Top Indian drug giant Sun Pharmaceutical Industries said Monday it had agreed to buy its troubled peer Ranbaxy for $4.0 billion in stock, ending its ill-fated six-year control by Japan's Daiichi Sankyo.

Indian drug maker Sun to buy troubled peer Ranbaxy for $4.0 bln
©Reuters/Arnd Wiegmann
Novartis replaces top Japan executives over drug trial scandal

Swiss pharmaceutical giant Novartis said Thursday it was replacing the top executives at its Japanese unit over allegations the division hid serious potential side effects of leukaemia treatments from regulators.

Novartis replaces top Japan executives over drug trial scandal
Photo courtesy of thepharmaletter.com
New Japan research scandal brewing over Alzheimer's study

Japan's health ministry said Friday it was probing claims falsified data was used in an Alzheimer's disease study involving major pharmaceutical firms, a day after filing an unrelated criminal complaint against Swiss drugs giant Novartis.

New Japan research scandal brewing over Alzheimer's study
Japan's top drugmaker appoints first foreign boss
Japan's top drugmaker appoints first foreign boss

Japan's top drugmaker said Saturday it had picked a GlaxoSmithKline executive as its next president in a rare example of overseas head-hunting by a major Japanese firm.

Japan's top drugmaker appoints first foreign boss
©Reuters/Luke MacGregor
GSK to seek green light for malaria vaccine

British drug maker GlaxoSmithKline (GSK) said on Tuesday it hoped to get the green light for a prototype vaccine against malaria after trials showed it offered children a partial shield against the disease.

GSK to seek green light for malaria vaccine
©REUTERS/Luke MacGregor
China details charges against foreign fraud investigators

Chinese state television put two foreign fraud investigators on display Tuesday as police announced they had been charged with illegally obtaining personal information.

China details charges against foreign fraud investigators
©REUTERS/Paul McErlane
US fines Wyeth $490.9 mn for illegal drug marketing

Wyeth Pharmaceuticals has pleaded guilty to misbranding a drug that prevents the rejection of organ transplants and agreed to pay $490.9 million.

US fines Wyeth $490.9 mn for illegal drug marketing
Pfizer to invest in clinical tests in Kazakhstan
Pfizer to invest in clinical tests in Kazakhstan

The pharmaceutical giant will invest in development of clinical test centers in Kazakhstan.

Pfizer to invest in clinical tests in Kazakhstan
World Trade Organization (WTO) Director-General Pascal Lamy. ©REUTERS
Poorest WTO members win new patent-rule waiver

The globe's poorest nations have won an eight-year extension of a waiver on intellectual property rules, but still need to hold talks on the vexed issue of pharmaceutical patents.

Poorest WTO members win new patent-rule waiver
©REUTERS
UPS to pay $40 million for illegal pharma shipments

UPS Friday agreed to forfeit $40 million and implement a compliance program after a Department of Justice probe found the company delivered drugs on behalf of illegal online pharmacies.

UPS to pay $40 million for illegal pharma shipments
Photo by Vladimir Dmitriyev©
Kazakhstan’s pharmaceutical market to grow 15 percent in 2013

The volume of Kazakhstan pharmaceutical market makes $1.2 billion; it has been maintaining an upward trend for several years already.

Kazakhstan’s pharmaceutical market to grow 15 percent in 2013
Photo courtesy of wn.com
US drug firm Mylan to buy Indian firm for $1.6 bn

US generic drugs specialist Mylan said Thursday it would buy a unit of India's pharma firm Strides Arcolab for $1.6 billion, boosting its presence in the high-growth injectable drugs market.

US drug firm Mylan to buy Indian firm for $1.6 bn
Pfizer unit Zoetis makes strong market debut
Pfizer unit Zoetis makes strong market debut

Zoetis, pharmaceutical giant Pfizer's animal-health division, made a dramatic debut on Wall Street Friday as the biggest initial public offering since Facebook.

Pfizer unit Zoetis makes strong market debut
Photo courtesy of gorodanapa.ru
Turkish Abdi Ibrahim bought Kazakhstan pharmaceutics company

Turkish company Abdi Ibrahim has purchased 60 percent in Kazakhstan’s Global Pharm.

Turkish Abdi Ibrahim bought Kazakhstan pharmaceutics company

Firebase Cloud Messaging